Pharmacokinetic and Pharmacodynamic Interactions Between Henagliflozin, a Novel Selective SGLT-2 Inhibitor, and Warfarin in Healthy Chinese Subjects
Xuejun He, Gege Liu, Xinyan Chen, Yaqin Wang, Ran Liu, Changmao Wang, Yunzhe Huang, Jie Shen, Yuanwei Jia
Topics & Concepts
CmaxMedicineWarfarinPharmacokineticsPharmacodynamicsPharmacologyInternal medicineAtrial fibrillationDiabetes Treatment and ManagementPotassium and Related DisordersPancreatic function and diabetes